Oczenski W, Fitzgerald R D, Schwarz S
Department for Anaesthesia and Intensive Care Medicine, City of Vienna Hospital, Lainz, Austria.
Eur J Anaesthesiol. 1998 Mar;15(2):202-9.
Procalcitonin, a new innovative inflammation parameter is presently being evaluated in clinical studies. It has been shown to be increased markedly in patients with severe bacteria induced inflammation, septic shock, endotoxinaemia and multiple organ failure. In contrast, severe viral infections or inflammatory reactions of non-infectious origin as well as auto-immune or allergic disorders do not or only very moderately increase procalcitonin serum levels. Because procalcitonin is observed at significantly higher concentrations in bacterial infections, it might assist differentiation between these infections and other aetiologies of critical illnesses. Furthermore, procalcitonin correlates with the severity of infection and sepsis and thus could serve as a useful marker for monitoring surgical high risk patients. Procalcitonin may serve as a valid and sensitive indicator for bacterial infection with important diagnostic potential in the peri-operative period and in intensive care medicine.
降钙素原是一种新型的炎症指标,目前正在临床研究中进行评估。已证明在严重细菌感染、感染性休克、内毒素血症和多器官功能衰竭患者中,降钙素原水平会显著升高。相比之下,严重病毒感染、非感染性炎症反应以及自身免疫或过敏性疾病不会或仅非常轻微地升高降钙素原血清水平。由于在细菌感染中观察到降钙素原浓度显著更高,它可能有助于区分这些感染与其他危重病病因。此外,降钙素原与感染和脓毒症的严重程度相关,因此可作为监测外科高危患者的有用标志物。降钙素原可作为细菌感染的有效且敏感指标,在围手术期和重症监护医学中具有重要的诊断潜力。